The association of Varicella zoster virus reactivation with Bell's palsy in children

International Journal of Pediatric Otorhinolaryngology

Volumn 79, Issue 3, 2015, Pages 328-331

  Abdel Aziz, Mosaad ^a   Azab, Noha A ^b   Khalifa, Badwy ^a   Rashed, Mohammed ^c   Naguib, Nader ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c BENI SUEF UNIVERSITY   (Egypt)

Author keywords

Bell's palsy; Facial paralysis; Varicella zoster virus; Zoster sine herpete

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PREDNISOLONE; ANTIVIRUS AGENT; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BELL PALSY; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES ZOSTER; HOUSE BRACKMANN FACIAL NERVE GRADING SCALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; VIRUS REACTIVATION; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; COMPLICATION; PHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS ACTIVATION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BELL PALSY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 84924902075     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2014.12.010     Document Type: Article

References (25)

1. Adour K.K., Byl F.M., Hilsinger R.L., Kahn Z.M., Sheldon M.I. The true nature of Bell's palsy: analysis of 1000 consecutive patients. Laryngoscope 1978, 88:787-801.
2. Rowlands S., Hooper R., Hughes R., Burney P. The epidemiology and treatment of Bell's palsy in the UK. Eur. J. Neurol. 2002, 9:63-67.
3. Hussain S.S.M. Facial paralysis in childhood. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery 2008, vol. 3:1052-1062. Oxford University Press, London, UK. seventh ed.
4. Taverner D. Cortisone treatment of Bell's palsy. Lancet 1954, 267:1052-1054.
5. Furuta Y., Ohtani F., Aizawa H., Fukuda S., Kawabata H., Bergstrom T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr. Infect. Dis. J. 2005, 24(2):97-101.
6. Michaels I. Histopathological changes in the temporal bone in Bell's palsy. Acta Otolaryngol. 1990, Suppl. 470:114-118.
7. Khine H., Mayers M., Avner J.R., Fox A., Herold B., Goldman D.L. Association between herpes simplex virus-1 infection and idiopathic unilateral facial paralysis in children and adolescents. Pediatr. Infect. Dis. J. 2008, 27(5):468-469.
8. Mori T., Nagai K., Asanuma H. Reactivation of varicella-zoster virus in facial palsy associated with infectious mononucleosis. Pediatr. Infect. Dis. J. 2002, 21:709-711.
9. Traavik T., Storvold G., Sundsfjord A., Lund S., Mair I.W. Peripheral facial palsy and coincidental cytomegalovirus infection or reactivation. Scand. J. Infect. Dis. 1983, 15:233-238.
10. Manning J.J., Adour K.K. Facial paralysis in children. Pediatrics 1972, 49:102-109.
11. Endo A., Izumi H., Miyashita M., Okubo O., Harada K. Facial palsy associated with mumps parotitis. Pediatr. Infect. Dis. J. 2001, 20:815-816.
12. Belec L., Gherandi R., Georges A.J. et al: Peripheral facial paralysis and HIV infection: report of four African cases and review of literature. J. Neurol. 1989, 236:411-414.
13. Shaw F.E., Graham D.J., Guess H.A. et al: Post-marketing surveillance for neurologic adverse events reported after hepatitis B vaccination experience of the first three years. Am. J. Epidemiol. 1988, 127:337-352.
14. Rogers R.S. Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol. Clin. 1996, 14(2):371-379.
15. House J.W., Brackmann D.E. Facial nerve grading system. Otolaryngol. Head Neck Surg. 1985, 93(2):146-147.
16. Cubukcu D., Yilmaz U., Alkan H., Metinkisi F., Ozcan M. Clinical features of Bell's Palsy in children and outcomes of physical therapy: a retrospective study. ISRN Rehabil. 2013, 2013:1.
17. de Ory F., Echevarría J.M., Kafatos G., Anastassopoulou C., Andrews N., et al. European seroepidemiology network, 2: Standardisation of assays for seroepidemiology of varicella zoster virus. J. Clin. Virol. 2006, 36(2):111-118.
18. Weinmann S., Chun C., Mullooly J.P., et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J. Infect. Dis. 2008, 197(Suppl. 2):132-138.
19. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 2004, 72:174-179.
20. Ogita S., Terada K., Niizuma T., Kosaka Y., Kataoka N. Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella-zoster virus association. Pediatr. Int. 2006, 48(3):245-249.
21. Morgan M., Nathwani D. Facial palsy and infection: the unfolding story. Clin. Infect. Dis. 1992, 14:263-271.
22. Robillard R.B., Hilsinger R.L., Adour K.K. Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol. Head Neck Surg. 1986, 95:292-297.
23. Adour K.K. Otological complications of herpes zoster. Ann. Neurol. 1994, 35(Suppl.):62-64.
24. Murakami S., Hato N., Horiuchi J., Honda N., Gyo K., Yanagihara N. Treatment of Ramsay Hunt syndrome with acyclovirprednisone: significance of early diagnosis and treatment. Ann. Neurol. 1997, 41:353-357.
25. Furuta Y., Ohtani F., Mesuda Y., Fukuda S., Inuyama Y. Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology 2000, 55:708-710.